Figure 1.

Effect of Embelin treatment on viability of OSCC cells. A, Embelin (10–300 μM) were to treat with three types of the OSCC cells (SCC25, YD10B, and Ca9–22) for 24 h. B, Ca9–22 cell were treated with Embelin (5–30 μM) and cell viability was analyzed using the MTT assay. The data were calculated as percent of vehicle control and expressed as the mean of at least three experiments. Data were expressed as the mean ± SD (n = 6) and analyzed by one‐way ANOVA using Dunnett's multiple‐comparison test (*P < .05, **P < .01, ***P < .001 on SCC25; #P < .05, ##P < .01, ###P < .001 on YD10B; P < .05, P < .01, P < .001 on Ca9–22 for the difference between the control and treatment groups)